Search Results 681-690 of 18284 for Immunode

1. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

   Men or women of childbearing potential who are unwilling to employ adequate contraception. Known human immunodeficiency virus or acquired immunodeficiency ...

2. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

3. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   Subjects with a history of or active human immunodeficiency virus (HIV) are excluded. Subjects with uncontrolled systemic fungal, bacterial, viral or other ...

4. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

   Known infection with human immunodeficiency virus (HIV), hepatitis C, or a positive hepatitis B surface antigen; Inability to comply with study guidelines ...

5. Baricitinib in Relapsing Giant Cell Arteritis - Mayo Clinic

   Have known or documented diagnosis of human immunodeficiency virus (HIV). Have known or documented primary immunodeficiency. Have had household contact with ...

6. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Ongoing or active infection, known human immunodeficiency virus (HIV) positive, active hepatitis B or C infection. Systemic treatment with strong inhibitors ...

7. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness. Active infection that requires systemic treatment ...

8. Zoster Eye Disease Study - Clinical Trials

   Study participants who are diagnosed with Acquired Immune Deficiency Syndrome (AIDS) or presents with other clinical manifestations of Human Immunodeficiency ...

9. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

   Subjects with a known human immunodeficiency virus (e.g., HIV), other than that explained by the use of OCS or other therapy taken for HES. Other laboratory ...

10. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

    Have human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome-related illness. Have undergone major surgery within 28 days (≤28 ...